Mad Men's Hendricks named the face of the LATISSE Wishes Challenge

Share this article:
Mad Men's Hendricks named the face of the LATISSE Wishes Challenge
Mad Men's Hendricks named the face of the LATISSE Wishes Challenge

Emmy-nominated actress Christina Hendricks, of Mad Men fame, has signed on as the spokesperson for the LATISSE Wishes Challenge, co-launched by Allergan, LATISSE's manufacturer, and the Make-a-Wish Foundation. For the second year running, the pharma company and the non-profit have teamed up to raise money on behalf of the foundation, with this year's goal of raising $500,000 to grant a wish in every Make-A-Wish chapter across the country.

“I've always felt my lashes were short and thin, and in my profession, I wear a lot of false lashes and makeup, which take a toll. So when LATISSE became available, I was curious to learn more,” said Hendricks in a statement. “LATISSE is also a brand that contributes to children, and I couldn't think of a better cause to support than the Make-A-Wish Foundation.”

Consumers can participate in the Challenge by donating a minimum of $20 to the Make-a-Wish Foundation through the campaign's website. LATISSE will double all donations up to $250,000 until November 30 of this year. For extra incentive, the first 10,000 participants to commit to the minimum donation will receive a LATISSE free trial certificate, which they can then discuss the benefits of with their doctor.

"Allergan is proud to continue its commitment to the Make-A-Wish Foundation,” said David Pyott, Chairman of the Board, President and CEO of Allergan, in a statement. “In just two years, LATISSE and the women across the country who use it have raised nearly $1.5 million to help the Make-A-Wish Foundation grant children's wishes. Women appreciate supporting a brand that gives back and that may also provide a solution for themselves. Through the LATISSE Wishes Challenge, women will join Hendricks to support a wonderful cause and learn more about LATISSE to see if it is right for them."

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...